Voyageur Pharmaceuticals (CVE:VM) Trading 47.4% Higher – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price shot up 47.4% on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares traded hands during mid-day trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Price Performance

The company has a 50 day moving average of C$0.08 and a two-hundred day moving average of C$0.06. The firm has a market cap of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.